Zobrazeno 1 - 10 of 452 pro vyhledávání: '"Norman M Kaplan"'
1
Elektronická kniha
Kaplan's Clinical Hypertension
Autor: Norman M. Kaplan, Ronald G. Vitor
The 11th Edition of Kaplan's Clinical Hypertension continues to integrate the latest basic science findings and clinical trial data to provide current, practical, evidence-based recommendations for treatment and prevention of all forms of hypertensio
Zobrazit plný text záznamu
2
Target Organ Complications and Cardiovascular Events Associated With Masked Hypertension and White-Coat Hypertension
Autor: Darren K. McGuire, Colby Ayers, Wanpen Vongpatanasin, James A. de Lemos, Danielle D. Tientcheu, Ronald G. Victor, Sandeep R Das, Amit Khera, Norman M. Kaplan
Publikováno v: Journal of the American College of Cardiology. 66(20):2159-2169
Background Multiple epidemiological studies from Europe and Asia have demonstrated increased cardiovascular risks associated with isolated elevation of home blood pressure (BP) or masked hypertension (MH). Previous studies have not addressed cardiova
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::591652ce7082ae8efdcff918399a622f
Zobrazit plný text záznamu
7
Target organ complications and prognostic significance of alerting reaction: analysis from the Dallas Heart Study
Autor: Colby Ayers, Ronald G. Victor, James A. de Lemos, Norman M. Kaplan, Alejandro Velasco, Wanpen Vongpatanasin, Sandeep R Das, Amit Khera
Publikováno v: Journal of hypertension, vol 34, iss 2
Objective Noninvasive blood pressure (BP) measurement often triggers a transient rise in BP, known as an alerting reaction. However, the prevalence and prognostic significance of the alerting reaction has never been assessed in the general population
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ace45081a5717b5a60b058c598465bb4
https://escholarship.org/uc/item/7b2874sv
Zobrazit plný text záznamu
8
Primary aldosteronism
Autor: Norman M. Kaplan
Publikováno v: Journal of Hypertension. 30:1899-1902
Primary aldosteronism is widely held to be the most common cause of identifiable (secondary) hypertension, reported to be present in 6-10% of all hypertensive patients. This belief reflects the widespread use of the aldosterone-to-renin ratio (ARR) a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::402cdb7b6a1400dbc9e59ff7e9d0a8b6
https://doi.org/10.1097/hjh.0b013e3283559a03
Zobrazit plný text záznamu
9
Primary aldosteronism: A contrarian view
Autor: Norman M. Kaplan
Publikováno v: Reviews in Endocrine and Metabolic Disorders. 12:49-52
This paper provides evidence that primary aldosteronism is likely much less common than is believed by the other authors of this collection. The basis for this contrarian view is simple: there is no way to know the true prevalence of PA because of th
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5367022accf7fc03882db80fe936c17
https://doi.org/10.1007/s11154-011-9160-x
Zobrazit plný text záznamu
10
Treating prehypertension: A review of the evidence
Autor: Norman M. Kaplan
Publikováno v: Current Hypertension Reports. 10:326-329
Although the term "prehypertension" has been challenged by some, its use to define people with systolic blood pressure (BP) between 120 and 139 mm Hg and/or diastolic pressures between 80 and 89 mm Hg has gained general acceptance. The category inclu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b406eaed98f553e07300237656791d57
https://doi.org/10.1007/s11906-008-0060-8
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje